IBA overview

Louvain-La-Neuve, Belgium, 2 May 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, today announces that it has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare and Proton International, for the installation of a Proteus ® ONE 1 compact proton therapy system. The contract includes a multi-year operation and maintenance agreement, and it is expected that the center...

GROUP REVENUES UP 18.7% WITH OTHER ACCELERATORS UP 51.1% REBIT POSITIVE FOR FY23 WITH OTHER ACCELERATORS REBIT ALMOST QUADRUPLING MEDIUM TERM GUIDANCE REITERATED Louvain-la-Neuve, Belgium, 21 March 2024 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the 2023 financial year. (EUR 000) FY 2023 FY 2022 Variance Variance % Total Net Sales 428 717 361 270 67 447 18.7% Proton Therapy 229 065 218 761 10 304 4.7% Other...

PanTera’s continues to deploy its strategy to become a market leader into the production and distribution of Ac225 Mol, Belgium, March 14, 2024: PanTera, the Belgian radioisotope producer created as a joint venture by IBA and SCK CEN with the primary goal to secure large-scale production of actinium-225 ( 225 Ac), today announces the signing of a strategic supply contract with an undisclosed partner. This second supply agreement from PanTera underscores its commitment to enabling the...

Contract with IAEA demonstrates Cyclone ® KEY’s accessibility for low- and middle-income countries Louvain-la-Neuve, Belgium, February 29, 2024 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, is pleased to announce that it has signed a contract for a Cyclone ® KEY cyclotron with the International Atomic Energy Agency (IAEA). This cyclotron will be installed at...

FY23 results meeting to take place as a hybrid event on Thursday, 21 March 2024 at 3pm CET Louvain-la-Neuve, Belgium, 26 February 2024 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today that it will publish its consolidated results for the full year 2023 on Thursday, 21 March 2024 at 7am CET. Conference Call Information IBA’s management team will host a hybrid event, including a conference call and webcast conducted in English, to...

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, February 20, 2024 06:00 Summary of the notification IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on February...